Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants

The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 2013-09, Vol.132 (3), p.e695-e703
Hauptverfasser:	Durrmeyer, Xavier, Hummler, Helmut, Sanchez-Luna, Manuel, Carnielli, Virgilio P, Field, David, Greenough, Anne, Van Overmeire, Bart, Jonsson, Baldvin, Hallman, Mikko, Mercier, Jean-Christophe, Marlow, Neil, Johnson, Samantha, Baldassarre, James
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Babies Bronchodilator Agents - administration & dosage Care and treatment Child, Preschool Clinical trials Demographic aspects European Union Female Follow-Up Studies Health aspects Hospitalization Humans Infant Infant, Newborn Male Menstruation Nitric oxide Nitric Oxide - administration & dosage Patient outcomes Pediatrics Premature birth Respiratory diseases Respiratory Distress Syndrome, Newborn - drug therapy Respiratory Distress Syndrome, Newborn - mortality Respiratory insufficiency Respiratory therapy Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union Nitric Oxide trial to age 2 years. In a multicenter, randomized, double-blind study, preterm infants born at
ISSN:	0031-4005 1098-4275
DOI:	10.1542/peds.2013-0007